Home/Filings/4/0001127602-23-030185
4//SEC Filing

Gayer Charles K 4

Accession 0001127602-23-030185

CIK 0000882796other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:38 PM ET

Size

4.7 KB

Accession

0001127602-23-030185

Insider Transaction Report

Form 4
Period: 2023-12-19
Gayer Charles K
Vice President and CCO
Transactions
  • Tax Payment

    Common Stock

    2023-12-19$6.05/sh2,482$15,016274,533 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001800110

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:38 PM ET
Size
4.7 KB